Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
Henan Taloph Pharmaceutical Stock Co Ltd
SSE:600222
|
3.8B CNY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.2B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.3B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.4B USD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Henan Taloph Pharmaceutical Stock Co Ltd
Glance View
Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the pharmaceutical manufacturing industry. The company is headquartered in Zhengzhou, Henan and currently employs 2,209 full-time employees. The firm provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The firm's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The firm distributes its products mainly within domestic market.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Henan Taloph Pharmaceutical Stock Co Ltd is 2.6%, which is above its 3-year median of 1.4%.
Over the last 3 years, Henan Taloph Pharmaceutical Stock Co Ltd’s Net Margin has increased from -4.4% to 2.6%. During this period, it reached a low of -4.4% on Aug 30, 2022 and a high of 5.4% on Jun 30, 2024.
